SI1000027T1 - Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it - Google Patents

Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it

Info

Publication number
SI1000027T1
SI1000027T1 SI9830442T SI9830442T SI1000027T1 SI 1000027 T1 SI1000027 T1 SI 1000027T1 SI 9830442 T SI9830442 T SI 9830442T SI 9830442 T SI9830442 T SI 9830442T SI 1000027 T1 SI1000027 T1 SI 1000027T1
Authority
SI
Slovenia
Prior art keywords
carbazolyloxy
propanole
methoxyphenoxy
ethylamino
preparation
Prior art date
Application number
SI9830442T
Other languages
English (en)
Slovenian (sl)
Inventor
Erhard Reinholz
Peter Beyer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of SI1000027T1 publication Critical patent/SI1000027T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SI9830442T 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it SI1000027T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (en) 1997-07-22 1997-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
EP98937576A EP1000027B1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
PCT/EP1998/004475 WO1999005105A1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
SI1000027T1 true SI1000027T1 (en) 2003-10-31

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830442T SI1000027T1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it

Country Status (31)

Country Link
EP (2) EP0893440A1 (cs)
JP (1) JP2001510824A (cs)
KR (1) KR100336229B1 (cs)
CN (1) CN1125047C (cs)
AR (1) AR015133A1 (cs)
AT (1) ATE236123T1 (cs)
AU (1) AU740453B2 (cs)
BR (1) BR9810776A (cs)
CA (1) CA2296637C (cs)
CZ (1) CZ296947B6 (cs)
DE (1) DE69812964T2 (cs)
DK (1) DK1000027T3 (cs)
ES (1) ES2195366T3 (cs)
HR (1) HRP980406A2 (cs)
HU (1) HUP0003198A3 (cs)
IL (1) IL133677A (cs)
MA (1) MA26523A1 (cs)
MY (1) MY117734A (cs)
NO (1) NO313588B1 (cs)
NZ (1) NZ502136A (cs)
PE (1) PE96999A1 (cs)
PL (1) PL191602B1 (cs)
PT (1) PT1000027E (cs)
RU (1) RU2202542C2 (cs)
SI (1) SI1000027T1 (cs)
TR (1) TR200000148T2 (cs)
TW (1) TW505631B (cs)
UY (1) UY25108A1 (cs)
WO (1) WO1999005105A1 (cs)
YU (1) YU2200A (cs)
ZA (1) ZA986475B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2227206T3 (es) * 2000-04-03 2005-04-01 F. Hoffmann-La Roche Ag Soluciones concentradas de carvedilol.
MXPA02012795A (es) 2000-06-28 2004-07-30 Teva Pharma Carvedilol.
EP1655285A1 (en) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Method for preparation of a crystalline form of carvedilol (form II)
ATE328595T1 (de) * 2001-07-13 2006-06-15 Smithkline Beecham Corp Carvedilolpolymorph
DK1429734T3 (da) 2001-09-21 2008-05-13 Egalet As Faste dispersioner af carvedilol til kontrolleret afgivelse
MXPA04002826A (es) * 2001-09-28 2004-07-02 Hoffmann La Roche Formas pseudopolimorficas de carvedilol.
HRP20040673A2 (en) 2002-01-15 2005-06-30 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
WO2003092622A2 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
EP1539140A4 (en) 2002-06-27 2005-12-07 Sb Pharmco Inc CARVEDILOLHYDOBROMID
WO2004002419A2 (en) 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
WO2004041252A1 (en) * 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
ATE495732T1 (de) 2003-03-26 2011-02-15 Egalet As Morphin-system mit kontrollierter freisetzung
US7468442B2 (en) 2003-04-21 2008-12-23 Matrix Laboratories Ltd. Process for the preparation of carvedilol form-II
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
EP1686986A4 (en) * 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
CN100591668C (zh) * 2004-12-09 2010-02-24 Zach系统股份公司 制备卡维地洛及其对映异构体的方法
EP1781611A1 (en) * 2005-06-09 2007-05-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
WO2008002683A2 (en) 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Polymorphous forms of carvedilol phosphate
RU2366653C2 (ru) * 2006-07-03 2009-09-10 Ооо "Нанокриохимия" Способ получения рентгеноаморфной модификации карведилола
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
AU2010211220B2 (en) 2009-02-06 2013-08-01 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ603579A (en) 2009-06-24 2014-02-28 Egalet Ltd Controlled release formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
MY117734A (en) 2004-07-31
CA2296637A1 (en) 1999-02-04
HUP0003198A3 (en) 2002-10-28
JP2001510824A (ja) 2001-08-07
HUP0003198A2 (en) 2001-03-28
BR9810776A (pt) 2000-09-19
HRP980406A2 (en) 1999-04-30
AU8631998A (en) 1999-02-16
PE96999A1 (es) 1999-10-12
EP1000027A1 (en) 2000-05-17
NO20000301L (no) 2000-01-21
DE69812964T2 (de) 2004-03-04
PL338432A1 (en) 2000-11-06
DE69812964D1 (de) 2003-05-08
EP0893440A1 (en) 1999-01-27
IL133677A0 (en) 2001-04-30
PT1000027E (pt) 2003-07-31
CN1125047C (zh) 2003-10-22
TR200000148T2 (tr) 2000-07-21
DK1000027T3 (da) 2003-07-21
KR20010022097A (ko) 2001-03-15
RU2202542C2 (ru) 2003-04-20
TW505631B (en) 2002-10-11
CN1264366A (zh) 2000-08-23
CA2296637C (en) 2005-11-15
NZ502136A (en) 2002-05-31
IL133677A (en) 2004-06-01
YU2200A (sh) 2002-03-18
CZ2000221A3 (cs) 2000-05-17
AU740453B2 (en) 2001-11-01
AR015133A1 (es) 2001-04-18
WO1999005105A1 (en) 1999-02-04
ES2195366T3 (es) 2003-12-01
UY25108A1 (es) 2000-12-29
EP1000027B1 (en) 2003-04-02
KR100336229B1 (ko) 2002-05-09
CZ296947B6 (cs) 2006-08-16
HK1029339A1 (en) 2001-03-30
ATE236123T1 (de) 2003-04-15
NO313588B1 (no) 2002-10-28
PL191602B1 (pl) 2006-06-30
ZA986475B (en) 2000-01-21
MA26523A1 (fr) 2004-12-20
NO20000301D0 (no) 2000-01-21

Similar Documents

Publication Publication Date Title
SI1000027T1 (en) Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
HUP0203257A3 (en) Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them
HUP0100225A3 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
HUP0000721A3 (en) Gemcitabine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0100431A3 (en) Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them
IL120699A0 (en) Indole derivatives and pharmaceutical compositions containing them
HUP9802422A3 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
HUP0000323A3 (en) N-substituted 2-cyanopyrrolidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9801045A3 (en) Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation
HUP0200309A2 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
HUP0001541A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
HUP0002830A3 (en) Indole and 2,3-dihydroindole derivatives, their preparation, use, and pharmaceutical compositions containing them
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
SI0918059T1 (en) Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
IL112627A0 (en) Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them
ZA983997B (en) Triazole derivatives, process for their preparation and pharmaceutical compositions containing them.
HUP0003053A3 (en) Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them
HUP9802121A3 (en) Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
AU9416201A (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
EE200200331A (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0100785A3 (en) Indole derivatives, process for producing them and pharmaceutical compositions containing them